The pharmacotechnological studies of the phytospecies composition for the complex therapy of mastopathy
Keywords:medicinal plant raw material, phytospecies, pharmacotechnological parameters, mastopathy
Today mastopathy is the most common benign breast disease. It is diagnosed in almost one in four women aged 30 years. In women over 40 different breast pathologies are found in 60 % of cases. Mastopathy that has not been diagnosed in proper time and corrected pharmacologically can be the cause of breast cancer. The urgency of the problem is caused by widespread mastopathy and currently ineffective treatment of this disease.
Aim. To study the pharmacotechnological parameters of the medicinal plant raw material (MPRM) in order to create a phytospecies for use in the treatment of mastopathy.
Materials and methods. Using the technological research methods according to the State Pharmacopoeia of Ukraine and the method described by P. Vetrov the main technological characteristics of the raw material such as the content of extractive substances, specific density, bulk volume, and bulk density, pore volume, porosity, and free volume of the layer for MPRM under research and the phytospecies developed were studied. The technological parameters of different types of the plant raw material are determined by the following methods given above. The raw material was previously crushed to the particle size of 0.3-0.6 cm by the combined method. The data obtained were processed by the methods of economic and statistical analysis of the treatment results using computer programs.
Results and discussion. The main technological parameters of the raw material are moisture, the content of extractive substances, specific density, bulk volume, and bulk density of the raw material, pore volume, porosity and free volume of the layer of the raw material. The results obtained when studying the main technological parameters of MPRM in the composition of the drug developed allow us to determine the optimal ratio between the raw material and the extractant, choose the type and size of packing of the phytospecies. Based on the analysis of the chemical composition and pharmacological properties of active substances of MPRM and the results of the technological studies the composition of the phytospecies for the complex treatment of mastopathy has been developed. The data obtained will serve as a basis for choosing the parameters of extraction and type of packing of a drug.
Conclusions. The main pharmacotechnological parameters of the samples of MPRM (parsley leaves, corn silk, cranberry fruits, hop cones, common horsetail herb, rose hips, nettle leaves, stevia herb) and the phytospecies have been determined. The phytospecies developed can be used as a medicated product in the treatment of mastopathy due to the presence of the hormone-regulating, oncoprotective, choleretic, diuretic and immunomodulatory action.
Mostovyi, H. I., Dihtiar, A. O., Harkavyi, V. K. et al. (2002). Teoriia statystyky. Kharkiv: Mahistr, 300.
Zabara, I. P., Zujkina, S. S. (2015). Innovatcii v meditcine i farmatcii.Minsk, 857–860.
Konovalenko, I.S., Polovko, N. P. (2016). Modern achievments of pharmaceutical technology and biotechnology, 318–321.
Tovstanovskaia, V. A., Vorobei–Vikhovskaia, V. N., Sakharova, I.A. (2010). Zdorove zhenshchiny, 1 (47), 64–66.
Tatarchuk, T. F., Kalugina, L. V., Efimenko, O. A. (2012). Reproduktivnaia endokrinologiia, 3 (5), 53–57.
Vishnevscka, L. I., Bavykina, M. L., Megalinskyi, V. A., Sinitsina, O. S., Zujkina, S. S. (2016). Chromatography – mass spectrometry determination of volatile compounds in intravaginal combined gel on the basis of hop cones. The Pharma Innovation, 5 (5), 39–42.
Zujkina, S. S., Vyshnevska, L. I. (2016). Fitohormony v terapii mastopatii. Kharkiv, 116–117.
Liu, Y., Colditz, G. A., Rosner, B., Berkey, C. S., Collins, L. C., Schnitt, S. J., Tamimi, R. M. (2013). Alcohol Intake Between Menarche and First Pregnancy: A Prospective Study of Breast Cancer Risk. JNCI Journal of the National Cancer Institute, 105 (20), 1571–1578. doi: 10.1093/jnci/djt213
Miller, P. E., Snyder, D. C. (2012). Phytochemicals and Cancer Risk. Nutrition in Clinical Practice, 27 (5), 599–612. doi:10.1177/0884533612456043
Subramanian, J., Karmegam, A., Papageorgiou, E., Papandrianos, N., Vasukie, A. (2015). An integrated breast cancer risk assessment and management model based on fuzzy cognitive maps. Computer Methods and Programs in Biomedicine, 118 (3), 280–297. doi:10.1016/j.cmpb.2015.01.001
Zujkina, S. S., Vishnevskaia, L. I. (2016). Farmatcevticheskii klaster kak integratciia nauki, obrazovaniia i proizvodstva.Belgorod : BelGU, 104–106.
Vetrov, P. P., Harna, S. V., Prokopenko, S. O., Kucher, O. V. (1987). Farmatsevtychnyi zhurnal, 3, 52–56.
13. Derzhavna Farmakopeia Ukrainy. (2nd ed.). (2015). Kharkiv: Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv, 3, 723.
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).